How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

ILTS Transplant Course --OR-- NASPGHAN Pediatric Symposium

Postgraduate Course

Hepatology Associates Course

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the following:

The program was relevant to my work.

Usefulness of handouts/AV.

Quality of facilities.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

Having completed the activity, please rate your ability to meet each of the following objectives:

Describe how recent knowledge from clinical investigation can be translated into optimal approaches to the management hepatobiliary malignancies before and after liver transplantation

Explain how to apply new developments in the strategies for the treatment of hepatitis B and C to the

transplant arena

Discuss the impact of and management strategies for donor transmitted infectious diseases

Discuss how to increase tumor awareness of those involved in the care of children with liver disease and direct them to patterns of referral to tertiary centers

Summarize the management of these rare conditions

Describe the current state of knowledge in basic and clinical sciences on the various forms of viral hepatitis

Discuss recent advances in the diagnosis, management and treatment of viral hepatitis and related liver disease

Evaluate the evidence underlying current strategies to prevent and treat viral hepatitis and related liver disease

Discuss individualizing HCV care in light of small molecules

Evaluate correct radiology management of the hepatology patient

Identify NAFLD progression

Explain the implications of advances in allocation strategies for high risk donor organs, immunosuppression and approaches to pre and posttransplant metabolic complications and renal insufficiency

Describe nutritional needs in the pre and post transplant patient

State the disease criteria of a benign or malignant liver lesion

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

Was the educational content free of commercial bias?

Was the mode of education effective to learning?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

If you answered "No" to any of the above questions, please explain.

Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?

If you answered "Yes" to the above question, please explain.

What did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?

What problems are your patients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (collectively, the four courses for which nurse credit was available) be improved to better impact competence, performance and/or patient outcomes?

Additional comments: